International Engineering & Technology Fair

December 26, 2016 Vijay Soni 0

International Engineering & Technology Fair 02-04 Feb 2017  Pragati Maidan, New Delhi, India 22nd IETF 2017 The International Engineering and Technology Fair is now in its 22nd edition. A comprehensive business-to-business event segmented into 11 focused engineering and manufacturing sections, the event is an unparalleled platform for networking and getting discovered [..]

Effect of “Ineffective” Treatment on Some Glioblastoma Patients

December 26, 2016 Vijay Soni 0

Effect of “Ineffective” Treatment on Some Glioblastoma Patients December 26, 2016 By KRISTA CONGER (Stanford News) A subgroup of patients with a devastating brain tumor called glioblastoma multiforme benefited from treatment with a class of chemotherapy drugs that two previous large clinical trials indicated was ineffective against the disease, according to a [..]

Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca

December 23, 2016 Vijay Soni 0

Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca December 23, 2016 Pfizer Inc. (NYSE:PFE) today announced that it has completed the acquisition of the development and commercialization rights to AstraZeneca’s late-stage small molecule anti-infective business, primarily outside the United States. The agreement includes the commercialization and development rights [..]

Artificial Leaf as Mini-Factory For Medicine

December 22, 2016 Vijay Soni 0

Artificial Leaf as Mini-Factory For Medicine Eindhoven University of Technology News December 22 2016 To produce medicine sustainably and cheaply, anywhere you want. Whether in the middle of the jungle or even on Mars. A ‘mini-factory’ whereby sunlight can be captured to make chemical products. Inspired by the art of [..]

Mystery Molecule is a Key to Inhibiting Colon Cancer

December 22, 2016 Vijay Soni 0

Mystery Molecule is a Key to Inhibiting Colon Cancer St. Jude Children’s Research Hospital News December 22, 2016 Immunologists at St. Jude Children’s Research Hospital have discovered that a protein called NLRC3 plays a central role in inhibiting colon cells from becoming cancerous. The study, led by Thirumala-Devi Kanneganti, Ph.D., [..]

FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer

December 22, 2016 Vijay Soni 0

FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer December 22, 2016   Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA) for its first-in-class CDK 4/6 inhibitor, IBRANCE® (palbociclib). The [..]

Microbiotica: Sangar Institute Spin-out; Will Get £8m Funding From Cambridge Innovation Capital plc and IP Group plc

December 21, 2016 Vijay Soni 0

Microbiotica: Sangar Institute Spin-out; Will Get £8m Funding From Cambridge Innovation Capital plc and IP Group plc By : Media Team Sangar Institute December 21, 2016 Cambridge Innovation Capital plc (CIC), a Cambridge-based investor in technology and healthcare companies, and IP Group plc, the developer of intellectual property-based businesses, announce the creation [..]

Sangar Institute Research Reveal Potential Drug Target From Largest Ever Genetic study of Primary Sclerosing Cholangitis

December 20, 2016 Vijay Soni 0

Sangar Institute Research Reveal Potential Drug Target From Largest Ever Genetic study of Primary Sclerosing Cholangitis By : Media Team Sangar Institute December 21, 2016 Primary Sclerosing Cholangitis (PSC) is a debilitating rare disease of the liver with no effective treatment. Reported in Nature Genetics researchers from the Wellcome Trust Sanger [..]

New Diabetes Approaches From Bacteria That Boost Insulin-Producing Cells

December 20, 2016 Vijay Soni 0

New Diabetes Approaches From Bacteria That Boost Insulin-Producing Cells By Lewis Taylor, University Communications December 21, 2016 A newly discovered bacterial protein produced in the zebrafish gut triggers insulin-producing beta cells of the pancreas to multiply during early larval development, say University of Oregon researchers. The research potentially has human health [..]

FDA Approved Rubraca™ (Rucaparib) of Clovis Oncology For the Treatment of Advanced Ovarian Cancer due to BRCA Mutations

December 20, 2016 Vijay Soni 0

FDA Approved Rubraca™ (Rucaparib) of Clovis Oncology For the Treatment of Advanced Ovarian Cancer due to BRCA Mutations December 20, 2016 Rubraca received approval under the FDA’s accelerated approval program based on objective response rate and duration of response Most common Grade 3-4 adverse reaction was anemia; most common Grade 3-4 laboratory [..]

Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older

December 19, 2016 Vijay Soni 0

  Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older Pfizer NEWS December 20, 2016 Pfizer Inc. (NYSE:PFE) announced that the European Commission (EC) has approved an expanded indication for Nimenrix™ (meningococcal group [..]

Open Source Leadership Summit 2017

December 18, 2016 Vijay Soni 0

Open Source Leadership Summit 2017 Dates: February 14-16, 2017 | Request an invitation here Submit a speaking proposal here Location: Lake Tahoe, The United States The Linux Foundation Open Source Leadership Summit is where the world’s thought leaders in open source software and collaborative development convene to share best practices and learn how [..]

Movable Microplatform Floats On a Sea of Droplets

December 18, 2016 Vijay Soni 0

Movable Microplatform Floats On a Sea of Droplets David L. Chandler | MIT News Office December 19, 2016 Microelectromechanical systems, or MEMS, are tiny machines fabricated using equipment and processes developed for the production of electronic chips and devices. They’ve found a wide variety of applications in today’s consumer electronics, [..]

A Leap in Bioinspired Robotics

December 18, 2016 Vijay Soni 0

A Leap in Bioinspired Robotics Jennifer Chu | MIT News Office December 19, 2016 In the not so distant future, first responders to a disaster zone may include four-legged, dog-like robots that can bound through a fire or pick their way through a minefield, rising up on their hind legs to [..]

Faster treatment for epilepsy

December 17, 2016 Vijay Soni 0

Faster treatment for epilepsy NUS News 16 December 2016 Researchers at Duke-NUS Medical School (Duke-NUS) have identified a gene network in the brain, that when disrupted, causes epilepsy. The team’s original “network biology” approach could also possibly provide a quicker and cheaper way to accelerate the discovery of novel drug [..]

FDA Clears Integration Between LifeScan’s OneTouch Verio Flex® Blood Glucose Monitoring System and WellDoc’s BlueStar® Diabetes Management Platform

December 17, 2016 Vijay Soni 0

FDA Clears Integration Between LifeScan’s OneTouch Verio Flex® Blood Glucose Monitoring System and WellDoc’s BlueStar® Diabetes Management Platform J&J News December 17, 2016 LifeScan, Inc., part of the Johnson & Johnson Diabetes Care Companies and a world leader in blood glucose monitoring, today announced the U.S. Food and Drug Administration (FDA) [..]

Novartis receives positive CHMP recommendation for Ilaris® to treat rare diseases in adults and children called Periodic Fever Syndromes

December 17, 2016 Vijay Soni 0

Novartis receives positive CHMP recommendation for Ilaris® to treat rare diseases in adults and children called Periodic Fever Syndromes Ilaris® (canakinumab) is recommended for approval in Europe for the treatment of three Periodic Fever Syndromes: TRAPS, HIDS/MKD and FMF disease   If approved, Ilaris will be the first and only [..]

FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling

December 17, 2016 Vijay Soni 0

FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling Labeling Revisions Also Include Updates to Corresponding Warning and Addition of Clinical Data on Superior Efficacy of CHANTIX Compared to Bupropion or Nicotine Patch1 Labeling Revisions May Further Encourage Smokers and Healthcare Providers to Discuss Smoking [..]

KEYTRUDA® (pembrolizumab) Demonstrated Improved Health-Related Quality of Life Compared to Chemotherapy in First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)

December 16, 2016 Vijay Soni 0

KEYTRUDA® (pembrolizumab) Demonstrated Improved Health-Related Quality of Life Compared to Chemotherapy in First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Findings Presented in Plenary Session at 17 th World Conference on Lung Cancer December 16, 2016 Merck (NYSE:MRK), known as MSD outside the United States and Canada, [..]

How do we keep GPS safe from sabotage?

December 16, 2016 Vijay Soni 0

How do we keep GPS safe from sabotage? By Edmund Andrews  (Stanford News) December 16, 2016 Aerial drones are already being used to televise football games, produce 3-D maps and tend farm fields. Uber, the giant ride-sharing company, is now testing a service with self-driving cars in Pittsburgh. China deploys unmanned patrol boats in [..]

SEO BootCamp

December 15, 2016 Vijay Soni 0

SEO BootCamp January 11-13, 2017, Dallas, TX The SEO Bootcamp, organized by the SEO Bootcamp will take place from 11th January to 13th January 2017 at the Level in Dallas, United States Of America. This Conference Will Cover Areas Like: – What really matters to Google and other search engines, [..]

Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide) Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer

December 15, 2016 Vijay Soni 0

Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide) Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer By: Pfizer Press Release December 15, 2016   Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503) today announced the Phase 4 PLATO study, evaluating the efficacy and safety of [..]